Inhibitors of DNA Polymerase III as Novel Antimicrobial Agents against Gram-Positive Eubacteria

AUTOR(ES)

Tarantino, Paul M.

FONTE

American Society for Microbiology

RESUMO

6-Anilinouracils are selective inhibitors of DNA polymerase III, the enzyme required for the replication of chromosomal DNA in gram-positive bacteria (N. C. Brown, L. W. Dudycz, and G. E. Wright, Drugs Exp. Clin. Res. 12:555–564, 1986). A new class of 6-anilinouracils based on N-3 alkyl substitution of the uracil ring was synthesized and analyzed for activity as inhibitors of the gram-positive bacterial DNA polymerase III and the growth of gram-positive bacterial pathogens. Favorable in vitro properties of N-3-alkyl derivatives prompted the synthesis of derivatives in which the R group at N-3 was replaced with more-hydrophilic methoxyalkyl and hydroxyalkyl groups. These hydroxyalkyl and methoxyalkyl derivatives displayed Ki values in the range from 0.4 to 2.8 μM against relevant gram-positive bacterial DNA polymerase IIIs and antimicrobial activity with MICs in the range from 0.5 to 15 μg/ml against a broad spectrum of gram-positive bacteria, including methicillin-resistant staphylococci and vancomycin-resistant enterococci. Two of these hydrophilic derivatives displayed protective activity in a simple mouse model of lethal staphylococcal infection.

Documentos Relacionados

• Biological Characterization of Novel Inhibitors of the Gram-Positive DNA Polymerase IIIC Enzyme
• In Vitro Antimicrobial Activities of Novel Anilinouracils Which Selectively Inhibit DNA Polymerase III of Gram-Positive Bacteria
• In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria.
• Novel pharmaceutical molecules against emerging resistant gram-positive cocci
• In Vitro Activities of Peptide Deformylase Inhibitors against Gram-Positive Pathogens